| 000 | 01409 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250517041657.0 | ||
| 264 | 0 | _c20160614 | |
| 008 | 201606s 0 0 eng d | ||
| 022 | _a1756-2651 | ||
| 024 | 7 |
_a10.1093/jb/mvv069 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTanaka, Yoshiya | |
| 245 | 0 | 0 |
_aRecent progress and perspective in JAK inhibitors for rheumatoid arthritis: from bench to bedside. _h[electronic resource] |
| 260 |
_bJournal of biochemistry _cSep 2015 |
||
| 300 |
_a173-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInflammation _xdrug therapy |
| 650 | 0 | 4 |
_aJanus Kinase 1 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aJanus Kinase 3 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aMethotrexate _xtherapeutic use |
| 650 | 0 | 4 |
_aPiperidines _xtherapeutic use |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aPyrimidines _xtherapeutic use |
| 650 | 0 | 4 |
_aPyrroles _xtherapeutic use |
| 650 | 0 | 4 |
_aSTAT1 Transcription Factor _xbiosynthesis |
| 650 | 0 | 4 | _aTranslational Research, Biomedical |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 773 | 0 |
_tJournal of biochemistry _gvol. 158 _gno. 3 _gp. 173-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/jb/mvv069 _zAvailable from publisher's website |
| 999 |
_c25053111 _d25053111 |
||